首页 | 本学科首页   官方微博 | 高级检索  
     

~(125)I粒子治疗原发性肝癌的研究与应用现状
引用本文:彭齐荣,肖必. ~(125)I粒子治疗原发性肝癌的研究与应用现状[J]. 医学综述, 2012, 18(23): 3960-3963
作者姓名:彭齐荣  肖必
作者单位:中国人民解放军第458医院全军肝病中心,广州,510602
摘    要:放射性粒子近距离治疗肿瘤是恶性肿瘤治疗的重要手段之一。近年来,125I粒子组织间植入治疗原发性肝癌应用于临床,在延长患者生存时间和提高患者生存质量等方面已取得良好效果。目前研究结果表明,125I粒子组织间植入治疗具有较好的安全性和有效性,为原发性肝癌肝癌的治疗提供了新的思路。现就近年来该技术的临床研究与应用予以综述。

关 键 词:肝癌  125I粒子  研究与应用

The Research and Application of 125I Seed Implantation Treatment for Primary Hepatic Carcinoma
PENG Qi-rong , XIAO Bi. The Research and Application of 125I Seed Implantation Treatment for Primary Hepatic Carcinoma[J]. Medical Recapitulate, 2012, 18(23): 3960-3963
Authors:PENG Qi-rong    XIAO Bi
Affiliation:1.Liver Disease Center,PLA 458th Hospital,Guangzhou 510602,China;2.Interventional Department,Guangdong Provincial People′s Hospital,Oncology Center of Guangdong Provincial Academy of Medical Sciences,Guangzhou 510080,China)
Abstract:Brahytherapy is one of the most important technologies in the treatment of malignant tumor.In recent years,125I seed brahytherapy in tissues treatment for primary hepatic carcinoma(PHC),is applied in clinical practice,which has achieved good results in prolonging survival time of patients and improving the quality of life.Compared with conventional therapies,125I seed brahytherapy for PHC has been demonstrated safe and effective,which provides a new approach for the treatment of PHC.Here is to make a review focusing on the clinical research and application of the technology.
Keywords:Primary hepatic carcinoma  125I seed  Research and application
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号